40m
Hosted on MSNLeerink Partners Initiates Coverage of aTyr Pharma (ATYR) with Outperform RecommendationFintel reports that on February 18, 2025, Leerink Partners initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a ...
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
A recent analysis by the Pharmaceutical Care Management Association estimates that Alabama’s proposed Senate Bill 99, (SB99), ...
Savant Capital LLC lifted its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 15.0% during the 4th ...
21h
ITWeb on MSNHow to master multi-level BOMs: The key to efficient pharma, manufacturing productionThe key to efficient pharma, manufacturing productionBy Anton Oosthiuizen, Commercial Director, QuickEasy SoftwareIssued by QuickEasy SoftwareJohannesburg, 18 Feb 2025Visit our press officeDon't let ...
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the stock. A number of ...
Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own over 10.1% of Japanese pharmaceuticals and food products manufac ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...
Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...
Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. Here are two important insights from that call that should excite investors about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results